Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Veterinary Vaccines"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 3357
Special Issue Editors
Interests: reverse vaccinology; veterinary vaccines; recombinant proteins
Interests: reverse vaccinology; veterinary vaccines; recombinant proteins; biotechnology
Special Issue Information
The field of veterinary vaccination has seen many significant advances in technologies over the past years, with the introduction of several vaccines based on novel recombinant DNA technology. In addition, improved knowledge of immune response mechanisms has brought successes in the development of vaccines that protect against challenging pathogens. Such vaccines have been successfully used to address many of the important veterinary and human diseases. With the current interest in One Health approaches to humans, animals, and the environment, veterinary vaccines have an important role to play in the development of further vaccine technologies.
The aim of this Special Issue is to present recent vaccination strategies that are now available and in development to the veterinary research worker. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Traditional vaccine technologies based on killed/inactivated and live/attenuated approaches;
- Live vectored vaccines;
- Modified live marker/differentiating infection in vaccinated animals;
- Recombinant subunit and protein vaccines;
- Peptide vaccines;
- Nucleic acid vaccines.
We look forward to receiving your contributions.
Dr. Silvana Beutinger Marchioro
Dr. Sibele Borsuk
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nucleic acid